BizNews BizNews Radio

Numsa investment co. plans to bring drugs from India, Russia to fight Covid-19 - Tim Modise interviews Khandani Msibi

Loading player...
In this interview with broadcaster Tim Modise, Khandani Msibi, CEO of Numsa Investment Company, talks about 3sixtyBiomedicine’s offering hope in fighting Covid19 by bringing Covid19 therapies Remdesevir from India and from Russia Avifavir to South Africa. He says the medications are likely to be made available in the country in two weeks. He also talks about the PPE-related corruption and the lost opportunity to empower black-owned businesses. Learn more about your ad choices. Visit megaphone.fm/adchoices
9 Aug 2020 8AM English South Africa Investing · Business News

Other recent episodes

BNC#8; John Endres Q&A - Jobs, politics and the investment freeze no one wants to admit

South Africa’s future hinges on one simple truth: jobs come from growth, and growth comes from political choices. This sharp discussion unpacks how policy, ideology, and global alignment are choking investment and costing livelihoods. Inside the ANC, paralysis, fear, and patronage block reform - despite clear evidence of what works…
10 Apr 9AM 32 min

Roy Tilley: The municipal "Rates Randage Monster" strangling South Africa's property owners

Durban businessman Roy Tilley says a deeply flawed municipal rates formula is pushing property owners and small businesses toward a financial breaking point. In this interview, the Queensmead industrial property owner explains why he believes ever-rising rates are becoming impossible to absorb, hurting tenants, jobs and investment, and argues that…
10 Apr 9AM 20 min

BNC#8: Magnus Heystek Q&A - The brutal truth about South Africa’s financial future

A sharp, no-holds-barred conversation on South Africa’s financial reality - rising offshore limits, shrinking property values, and the struggle for economic revival. From Johannesburg’s decline to gold’s surge, and investor psychology to policy failures, this discussion cuts through the noise. It’s a candid look at risk, resilience, and the tough…
10 Apr 6AM 34 min
All episodes